Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome

Pancreatic ductal adenocarcinoma (PDAC) is a tumor with a poor prognosis, and no targeted therapy is currently available. The aim of the present study was to investigate the prognostic significance of the expression of V-Ki-ras2 Κirsten rat sarcoma viral oncogene homolog (KRAS), downstream signaling...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncol Lett
Main Authors: Lemstrova, Radmila, Brynychova, Veronika, Hughes, David J., Hlavac, Viktor, Dvorak, Pavel, Doherty, Joanne E., Murray, Helena A., Crockard, Martin, Oliverius, Martin, Hlavsa, Jan, Honsova, Eva, Mazanec, Jan, Kala, Zdenek, Lovecek, Martin, Havlik, Roman, Ehrmann, Jiri, Strouhal, Ondrej, Soucek, Pavel, Melichar, Bohuslav, Mohelnikova-Duchonova, Beatrice
格式: Artigo
語言:Inglês
出版: D.A. Spandidos 2017
主題:
Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5661609/
https://ncbi.nlm.nih.gov/pubmed/29113235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6946
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍